Ambu A/S
Ambu A/S (AMBBY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ambby · pe ratio · data through Sep 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Ambu A/S (AMBBY) measures how much investors pay for each dollar of the company's trailing earnings. AMBBY's current PE ratio of 35.99x is calculated by dividing its stock price of $9.98 by its TTM earnings per share of $1.79. −73.3% discount vs 5Y avg 135.0x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-09-30
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 20 fiscal years · Front-end computedMinQ1 · 25%165.0x
MedianQ3 · 75%382.4x
Max
At 35.99x, AMBBY's current P/E is lower than in 0% of its annual fiscal year readings over the past 20 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Ambu A/SYou AMBBY | $2.6B | 35.99x | +20.9% | $1.79 |
 Amplifon S.p.A. AMFPF | $2.6B | 32.84x | +10.3% | $0.40 |
 Bumrungrad Hospital Public Company Limited BUHPF | $4.3B | 18.86x | -36.7% | $9.44 |
 Camurus AB (publ) CAMRF | $3.5B | 49.84x | +67.4% | $12.42 |
 Carl Zeiss Meditec AG CZMWF | $2.7B | 26.20x | -12.0% | $1.61 |
 Carl Zeiss Meditec AG CZMWY | $2.6B | 26.34x | -11.5% | $1.61 |
 Getinge AB (publ) GNGBF | $5.1B | 24.58x | -17.5% | $8.29 |
Industry Average 6 peers with valid PE | — | 29.78x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-09-30Latest FY2025 | 43.18x | $2.15 | -71.0% | |
2024-09-30 FY2024 | 148.71x | $0.88 | +27.6% | |
2023-09-30 FY2023 | 116.58x | $0.64 | -33.3% | |
2022-09-30 FY2022 | 174.85x | $0.37 | -8.7% | |
2021-09-30 FY2021 | 191.58x | $0.98 | +3.6% | |
2020-09-30 FY2020 | 184.88x | $0.98 | +103.7% | |
2019-09-30 FY2019 | 90.76x | $1.30 | -12.8% | |
2018-09-30 FY2018 | 104.06x | $1.39 | +53.1% | |
2017-09-30 FY2017 | 67.97x | $1.27 | -18.1% | |
2016-09-30 FY2016 | 82.95x | $1.05 | -40.4% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Ambu A/S (AMBBY) measures how much investors pay for each dollar of the company's trailing earnings. AMBBY's current PE ratio of 35.99x is calculated by dividing its stock price of $9.98 by its TTM earnings per share of $1.79.
Frequently asked questions
AMBBY pe ratio · 6 questionsAMBBY's current PE ratio is 35.99x as of 2026-06-09, based on a stock price of $9.98 and TTM EPS of $1.79. Data sourced from Financial Modeling Prep via AMBBY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Ambu A/S SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09